Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation
| Status: | Completed |
|---|---|
| Healthy: | No |
| Age Range: | 11 - 55 |
| Updated: | 7/15/2016 |
| Start Date: | December 2014 |
| End Date: | April 2016 |
Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation: A Non-inferiority Trial
To demonstrate non-inferiority of the efficacy of 200 mg mifepristone followed in 24 to 48
hours by 800 µg buccal misoprostol in outpatient medical abortion services among women 71-77
days' compared to women 64-70 days' LMP.
hours by 800 µg buccal misoprostol in outpatient medical abortion services among women 71-77
days' compared to women 64-70 days' LMP.
Inclusion Criteria:
- intrauterine pregnancy between 64 days and 77 days' LMP
- eligible for medical abortion according to study doctor assessment
- willing and able to sign consent form
- speak english or spanish (in US sites); speak the local language(s) (in international
sites)
- agree to comply with the study procedures and visit schedule
Exclusion Criteria:
- Have known allergies or present other contraindications to mifepristone or
misoprostol
We found this trial at
5
sites
1969 W Ogden Ave
Chicago, Illinois 60612
Chicago, Illinois 60612
(312) 864-6000
Principal Investigator: Ashlesha Patel, MD,MPH
John H. Stroger, Jr. Hospital of Cook County The Level 1 Trauma Center is one...
Click here to add this to my saved trials
Click here to add this to my saved trials
Baku,
Principal Investigator: Faiza Aliyeva, MD
Click here to add this to my saved trials
Chicago, Illinois 60630
Principal Investigator: Steve Lichtenberg, MD
Click here to add this to my saved trials
Click here to add this to my saved trials